Feedback / Questions
Imjudo (tremelimumab-actl) - AstraZeneca
azenosertib (ZN-c3) - Zentalis Pharma
Lynparza (olaparib) - Merck (MSD), AstraZeneca
onvansertib (PCM-075) - Cardiff Oncology
saruparib (AZD5305) - AstraZeneca
Cotellic (cobimetinib) - Exelixis, Roche
http://clinicaltrials.gov/ct2/show/NCT04005690
Sep 5, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next